554 related articles for article (PubMed ID: 33391517)
41. FGF8 promotes cell proliferation and resistance to EGFR inhibitors via upregulation of EGFR in human hepatocellular carcinoma cells.
Pei Y; Sun X; Guo X; Yin H; Wang L; Tian F; Jing H; Liang X; Xu J; Shi P
Oncol Rep; 2017 Oct; 38(4):2205-2210. PubMed ID: 28791365
[TBL] [Abstract][Full Text] [Related]
42. UHRF2 promotes Hepatocellular Carcinoma Progression by Upregulating ErbB3/Ras/Raf Signaling Pathway.
Sun J; Wu K; Chen S; Jiang S; Chen Y; Duan C
Int J Med Sci; 2021; 18(14):3097-3105. PubMed ID: 34400880
[TBL] [Abstract][Full Text] [Related]
43. β3 integrin promotes TGF-β1/H2O2/HOCl-mediated induction of metastatic phenotype of hepatocellular carcinoma cells by enhancing TGF-β1 signaling.
Feng XX; Liu M; Yan W; Zhou ZZ; Xia YJ; Tu W; Li PY; Tian DA
PLoS One; 2013; 8(11):e79857. PubMed ID: 24260309
[TBL] [Abstract][Full Text] [Related]
44. LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.
Liu J; Xu R; Mai SJ; Ma YS; Zhang MY; Cao PS; Weng NQ; Wang RQ; Cao D; Wei W; Guo RP; Zhang YJ; Xu L; Chen MS; Zhang HZ; Huang L; Fu D; Wang HY
Theranostics; 2020; 10(17):7527-7544. PubMed ID: 32685003
[TBL] [Abstract][Full Text] [Related]
45. APN-mediated phosphorylation of BCKDK promotes hepatocellular carcinoma metastasis and proliferation via the ERK signaling pathway.
Zhai M; Yang Z; Zhang C; Li J; Jia J; Zhou L; Lu R; Yao Z; Fu Z
Cell Death Dis; 2020 May; 11(5):396. PubMed ID: 32457292
[TBL] [Abstract][Full Text] [Related]
46. The noncoding RNA HOXD-AS1 is a critical regulator of the metastasis and apoptosis phenotype in human hepatocellular carcinoma.
Lu S; Zhou J; Sun Y; Li N; Miao M; Jiao B; Chen H
Mol Cancer; 2017 Jul; 16(1):125. PubMed ID: 28724429
[TBL] [Abstract][Full Text] [Related]
47. Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN.
Zhang QY; Men CJ; Ding XW
J Cell Biochem; 2019 Sep; 120(9):14885-14898. PubMed ID: 31044454
[TBL] [Abstract][Full Text] [Related]
48. T-box transcription factor 19 promotes hepatocellular carcinoma metastasis through upregulating EGFR and RAC1.
Ji X; Chen X; Zhang B; Xie M; Zhang T; Luo X; Liu D; Feng Y; Wang Y; Sun M; Li C; Huang W; Xia L
Oncogene; 2022 Apr; 41(15):2225-2238. PubMed ID: 35217793
[TBL] [Abstract][Full Text] [Related]
49. Enoyl-coenzyme A hydratase short chain 1 silencing attenuates the proliferation of hepatocellular carcinoma by inhibiting epidermal growth factor signaling in vitro and in vivo.
Lin BY; Xiao CX; Zhao WX; Xiao L; Chen X; Li P; Wang XM
Mol Med Rep; 2015 Jul; 12(1):1421-8. PubMed ID: 25760819
[TBL] [Abstract][Full Text] [Related]
50. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
51. Ginsenoside Rg3 Decreases NHE1 Expression via Inhibiting EGF-EGFR-ERK1/2-HIF-1
Li X; Tsauo J; Geng C; Zhao H; Lei X; Li X
Am J Chin Med; 2018; 46(8):1915-1931. PubMed ID: 30525897
[TBL] [Abstract][Full Text] [Related]
52. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
[TBL] [Abstract][Full Text] [Related]
53. Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma
Kang X; Wang F; Lan X; Li X; Zheng S; Lv Z; Zhuang Y; Zhao Y; Zhou S
Int J Med Sci; 2018; 15(1):69-76. PubMed ID: 29333089
[No Abstract] [Full Text] [Related]
54. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth.
Xu L; Feng X; Hao X; Wang P; Zhang Y; Zheng X; Li L; Ren S; Zhang M; Xu M
J Exp Clin Cancer Res; 2019 Feb; 38(1):98. PubMed ID: 30795787
[TBL] [Abstract][Full Text] [Related]
55. Tumour-suppressive role of PTPN13 in hepatocellular carcinoma and its clinical significance.
Zhan H; Jiang J; Luo C; Sun Q; Ke A; Sun C; Hu J; Hu Z; Hu B; Zhu K; Fan J; Zhou J; Huang X
Tumour Biol; 2016 Jul; 37(7):9691-8. PubMed ID: 26801674
[TBL] [Abstract][Full Text] [Related]
56. Upregulation of UBE2Q1 via gene copy number gain in hepatocellular carcinoma promotes cancer progression through β-catenin-EGFR-PI3K-Akt-mTOR signaling pathway.
Zhang B; Deng C; Wang L; Zhou F; Zhang S; Kang W; Zhan P; Chen J; Shen S; Guo H; Zhang M; Wang Y; Zhang F; Zhang W; Xiao J; Kong B; Friess H; Zhuge Y; Yan H; Zou X
Mol Carcinog; 2018 Feb; 57(2):201-215. PubMed ID: 29027712
[TBL] [Abstract][Full Text] [Related]
57. Rpn10 promotes tumor progression by regulating hypoxia-inducible factor 1 alpha through the PTEN/Akt signaling pathway in hepatocellular carcinoma.
Jiang Z; Zhou Q; Ge C; Yang J; Li H; Chen T; Xie H; Cui Y; Shao M; Li J; Tian H
Cancer Lett; 2019 Apr; 447():1-11. PubMed ID: 30673593
[TBL] [Abstract][Full Text] [Related]
58. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
[No Abstract] [Full Text] [Related]
59. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
60. TRIM50 suppressed hepatocarcinoma progression through directly targeting SNAIL for ubiquitous degradation.
Ma X; Ma X; Qiu Y; Zhu L; Lin Y; You Y; Ma D; Qin Z; Sun C; Zhao Y; Sun Y; Han L
Cell Death Dis; 2018 May; 9(6):608. PubMed ID: 29789583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]